Clonidine inhibits the canine external carotid vasodilatation to capsaicin by α2A/2C-adrenoceptors

European Journal of Pharmacology

Volumn 543, Issue 1-3, 2006, Pages 68-76

  Jiménez Mena, Luisa R ^a   Gupta, Saurabh ^b   Muñoz Islas, Enriqueta ^a   Lozano Cuenca, Jair ^a   Sánchez López, Araceli ^a   Centurión, David ^a   Mehrotra, Suneet ^b   MaassenVanDenBrink, Antoinette ^b   Villalón, Carlos M ^a  

^a Cinvestav Coapa   (Mexico)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

CGRP; BRL44408; Capsaicin; External carotid vasodilatation; Imiloxan; MK912

Indexed keywords

1,3,4,5',6,6',7,12B OCTAHYDRO 1',3' DIMETHYL 2H SPIRO[BENZO[B]FURO[2,3 A]QUINOLIZINE 2,4' PYRIMIDINE] 2' ONE; 2 (1 METHYL 2 ISOINDOLINYLMETHYL) 2 IMIDAZOLINE; ACETYLCHOLINE; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 2A ADRENERGIC RECEPTOR; ALPHA 2B ADRENERGIC RECEPTOR; ALPHA 2C ADRENERGIC RECEPTOR; ALPHA CALCITONIN GENE RELATED PEPTIDE; CAPSAICIN; CLONIDINE; IMILOXAN; RAUWOLSCINE; SODIUM CHLORIDE;

ANESTHESIA; ANIMAL EXPERIMENT; ARTERY DILATATION; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DOG; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG INHIBITION; EXTERNAL CAROTID ARTERY; HEART RATE; MALE; NONHUMAN; PRIORITY JOURNAL;

ACETYLCHOLINE; ADRENERGIC ALPHA-AGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CALCITONIN GENE-RELATED PEPTIDE; CAPSAICIN; CAROTID ARTERY, EXTERNAL; CLONIDINE; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART RATE; IMIDAZOLES; INDOLES; ISOINDOLES; MALE; PHENYLEPHRINE; QUINOLIZINES; RECEPTORS, ADRENERGIC, ALPHA-2; REPRODUCIBILITY OF RESULTS; VASODILATION; YOHIMBINE;

EID: 33746639183     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.05.041     Document Type: Article

References (50)

1. Arulmani U., MaassenVanDenBrink A., Villalón C.M., and Saxena P.R. Calcitonin gene-related peptide and its role in migraine pathophysiology. Eur. J. Pharmacol. 500 (2004) 315-330
2. Arulmani U., Gupta S., MaassenVanDenBrink A., Centurión D., Villalón C.M., and Saxena P.R. Experimental migraine models and their relevance in migraine therapy. Cephalalgia 26 (2006) 642-659
3. Averbeck B., Reeh P.W., and Michaelis M. Modulation of CGRP and PGE2 release from isolated rat skin by alpha-adrenoceptors and kappa-opioid-receptors. Neuroreport 12 (2001) 2097-2100
4. Buzzi M.G., Carter W.B., Shimizu T., Heath III H., and Moskowitz M.A. Dihydroergotamine and sumatriptan attenuate levels of CGRP in plasma in rat superior sagittal sinus during electrical stimulation of the trigeminal ganglion. Neuropharmacology 30 (1991) 1193-1200
5. Bylund D.B. Subtypes of alpha 1- and alpha 2-adrenergic receptors. FASEB J. 6 (1992) 832-839
6. Bylund D.B., Eikenberg D.C., Hieble J.P., Langer S.Z., Lefkowitz R.J., Minneman K.P., Molinoff P.B., Ruffolo Jr. R.R., and Trendelenburg U. International Union of Pharmacology nomenclature of adrenoceptors. Pharmacol. Rev. 46 (1994) 121-136
7. De Jonge A., Timmermans P.B., and Van Zwieten P.A. Participation of cardiac presynaptic alpha 2-adrenoceptors in the bradycardiac effects of clonidine and analogues. Naunyn-Schmiedeberg's Arch. Pharmacol. 317 (1981) 8-12
8. Deng P.Y., and Li Y.J. Calcitonin gene-related peptide and hypertension. Peptides 26 (2005) 1676-1685
9. Devedjian J.C., Esclapez F., is-Pouxviel C., and Paris H. Further characterization of human alpha 2-adrenoceptor subtypes: [3H]RX821002 binding and definition of additional selective drugs. Eur. J. Pharmacol. 252 (1994) 43-49
10. Docherty J.R. Subtypes of functional alpha1- and alpha2-adrenoceptors. Eur. J. Pharmacol. 361 (1998) 1-15
11. Dux M., Santha P., and Jancso G. Capsaicin-sensitive neurogenic sensory vasodilatation in the dura mater of the rat. J. Physiol. 552 (2003) 859-867
12. Edvinsson L. Blockade of CGRP receptors in the intracranial vasculature: a new target in the treatment of headache. Cephalalgia 24 (2004) 611-622
13. Ernsberger P., Meeley M.P., Mann J.J., and Reis D.J. Clonidine binds to imidazole binding sites as well as alpha 2-adrenoceptors in the ventrolateral medulla. Eur. J. Pharmacol. 134 (1987) 1-13
14. Goadsby P.J., Edvinsson L., and Ekman R. Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system. Ann. Neurol. 23 (1988) 193-196
15. Goadsby P.J., Lipton R.B., and Ferrari M.D. Migraine-current understanding and treatment. N. Engl. J. Med. 346 (2002) 257-270
16. Göthert M., Bruss M., Bonisch H., and Molderings G.J. Presynaptic imidazoline receptors. New developments in characterization and classification. Ann. N.Y. Acad. Sci. 881 (1999) 171-184
17. Guimarães S., and Moura D. Vascular adrenoceptors: an update. Pharmacol. Rev. 53 (2001) 319-356
18. Jasper J.R., Lesnick J.D., Chang L.K., Yamanishi S.S., Chang T.K., Hsu S.A., Daunt D.A., Bonhaus D.W., and Eglen R.M. Ligand efficacy and potency at recombinant alpha2 adrenergic receptors: agonist-mediated [35S]GTPgammaS binding. Biochem. Pharmacol. 55 (1998) 1035-1043
19. Kapoor K., Arulmani U., Heiligers J.P., Garrelds I.M., Willems E.W., Doods H., Villalón C.M., and Saxena P.R. Effects of the CGRP receptor antagonist BIBN4096BS on capsaicin-induced carotid haemodynamic changes in anaesthetised pigs. Br. J. Pharmacol. 140 (2003) 329-338
20. Kapoor K., Arulmani U., Heiligers J.P., Willems E.W., Doods H., Villalón C.M., and Saxena P.R. Effects of BIBN4096BS on cardiac output distribution and on CGRP-induced carotid haemodynamic responses in the pig. Eur. J. Pharmacol. 475 (2003) 69-77
21. Kawasaki H., Nuki C., Saito A., and Takasaki K. Adrenergic modulation of calcitonin gene-related peptide (CGRP)-containing nerve-mediated vasodilation in the rat mesenteric resistance vessel. Brain Res. 506 (1990) 287-290
22. Kleinman L.I., and Radford E.P. Ventilation standards for small mammals. J. Appl. Physiol. 19 (1964) 360-362
23. Langer S.Z. Presynaptic regulation of the release of catecholamines. Pharmacol. Rev. 32 (1980) 337-362
24. Markowitz S., Saito K., and Moskowitz M.A. Neurogenically mediated plasma extravasation in dura mater: effect of ergot alkaloids. A possible mechanism of action in vascular headache. Cephalalgia 8 (1988) 83-91
25. Matsubara T., Moskowitz M.A., and Huang Z. UK-14,304, R(-)-alpha-methyl-histamine and SMS 201-995 block plasma protein leakage within dura mater by prejunctional mechanisms. Eur. J. Pharmacol. 224 (1992) 145-150
26. Nicholas A.P., Pieribone V., and Hokfelt T. Distributions of mRNAs for alpha-2 adrenergic receptor subtypes in rat brain: an in situ hybridization study. J. Comp. Neurol. 328 (1993) 575-594
27. Peroutka S.J. Neurogenic inflammation and migraine: implications for the therapeutics. Mol. Interv. 5 (2005) 304-311
28. Piascik M.T., Soltis E.E., Piascik M.M., and Macmillan L.B. Alpha-adrenoceptors and vascular regulation: molecular, pharmacologic and clinical correlates. Pharmacol. Ther. 72 (1996) 215-241
29. Potenza M.A., De S.G., Montagnani M., Serio M., and Mitolo-Chieppa D. Vasodilatation induced by capsaicin in rat mesenteric vessels is probably independent of nitric oxide synthesis. Pharmacol. Res. 30 (1994) 253-261
30. Schafer U., Burgdorf C., Engelhardt A., Kurz T., and Richardt G. Presynaptic effects of moxonidine in isolated buffer perfused rat hearts: role of imidazoline-1 receptors and alpha2-adrenoceptors. J. Pharmacol. Exp. Ther. 303 (2002) 1163-1170
31. Silberstein S.D. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 55 (2000) 754-762
32. Silberstein S.D. Migraine. Lancet 363 (2004) 381-391
33. Steel R.G.D., and Torrie J.H. Principles and Procedures of Statistics. A Biomedical Approach. 2nd edition (1980), McGraw-Hill Kogakusha Ltd., Tokyo
34. Stone L.S., Broberger C., Vulchanova L., Wilcox G.L., Hokfelt T., Riedl M.S., and Elde R. Differential distribution of alpha2A and alpha2C adrenergic receptor immunoreactivity in the rat spinal cord. J. Neurosci. 18 (1998) 5928-5937
35. Takeda M., Ikeda M., Tanimoto T., Lipski J., and Matsumoto S. Changes of the excitability of rat trigeminal root ganglion neurons evoked by alpha(2)-adrenoreceptors. Neuroscience 115 (2002) 731-741
36. Timmermans P.B., Brands A., and Van Zwieten P.A. Lipophilicity and brain disposition of clonidine and structurally related imidazolidines. Naunyn-Schmiedeberg's Arch. Pharmacol. 300 (1977) 217-226
37. Travagli R.A., and Williams J.T. Endogenous monoamines inhibit glutamate transmission in the spinal trigeminal nucleus of the guinea-pig. J. Physiol. 491 Pt 1 (1996) 177-185
38. Uhlen S., Porter A.C., and Neubig R.R. The novel alpha-2 adrenergic radioligand [3H]-MK912 is alpha-2C selective among human alpha-2A, alpha-2B and alpha-2C adrenoceptors. J. Pharmacol. Exp. Ther. 271 (1994) 1558-1565
39. Velasco M., and Luchsinger A. Central acting antihypertensive drugs: past, present and future. Am. J. Ther. 2 (1995) 255-257
40. Villalón C.M., Terrón J.A., and Hong E. Role of 5-HT1-like receptors in the increase in external carotid blood flow induced by 5-hydroxytryptamine in the dog. Eur. J. Pharmacol. 240 (1993) 9-20
41. 1D receptor subtype. Naunyn-Schmiedeberg's Arch. Pharmacol. 354 (1996) 550-556
42. 2-adrenoceptors. Br. J. Pharmacol. 126 (1999) 585-594
43. Villalón C.M., Centurión D., Valdivia L.F., De Vries P., and Saxena P.R. An introduction to migraine: from ancient treatment to functional pharmacology and antimigraine therapy. Proc. West. Pharmacol. Soc. 45 (2002) 199-210
44. 2A/2C-adrenoceptors mediate external carotid vasoconstriction to dihydroergotamine. Eur. J. Pharmacol. 484 (2004) 287-290
45. Wang X.M., Zhang Z.J., Bains R., and Mokha S.S. Effect of antisense knock-down of alpha(2a)- and alpha(2c)-adrenoceptors on the antinociceptive action of clonidine on trigeminal nociception in the rat. Pain 98 (2002) 27-35
46. Willems E.W., Trion M., De V.P., Heiligers J.P., Villalón C.M., and Saxena P.R. Pharmacological evidence that alpha1- and alpha2-adrenoceptors mediate vasoconstriction of carotid arteriovenous anastomoses in anaesthetized pigs. Br. J. Pharmacol. 127 (1999) 1263-1271
47. Willems E.W., Valdivia L.F., Ramirez-San Juan E., Saxena P.R., and Villalón C.M. Pharmacological identification of the major subtypes of adrenoceptors involved in the canine external carotid vasoconstrictor effects of adrenaline and noradrenaline. Life Sci. 69 (2001) 143-153
48. Willems E.W., Valdivia L.F., Saxena P.R., and Villalón C.M. The role of several alpha(1)- and alpha(2)-adrenoceptor subtypes mediating vasoconstriction in the canine external carotid circulation. Br. J. Pharmacol. 132 (2001) 1292-1298
49. Willems E.W., Valdivia L.F., Saxena P.R., and Villalón C.M. Pharmacological profile of the mechanisms involved in the external carotid vascular effects of the antimigraine agent isometheptene in anaesthetised dogs. Naunyn-Schmiedeberg's Arch. Pharmacol. 364 (2001) 27-32
50. Williamson D.J., and Hargreaves R.J. Neurogenic inflammation in the context of migraine. Microsc. Res. Tech. 53 (2001) 167-178